Page last updated: 2024-10-28

hexamethylene bisacetamide and Nausea

hexamethylene bisacetamide has been researched along with Nausea in 3 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.

Research Excerpts

ExcerptRelevanceReference
"Hexamethylene bisacetamide was administered as a 5% (w/v) solution via a nasogastric or gastrostomy tube every 4 h for 5 days, followed in 21 days by a 5-day continuous i."2.67Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube. ( Chun, HG; Kelley, JA; Leyland-Jones, B; Lombardo, FA; Roth, JS; Ward, FT; Weiss, RB, 1991)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ward, FT1
Kelley, JA1
Roth, JS1
Lombardo, FA1
Weiss, RB1
Leyland-Jones, B1
Chun, HG1
Rowinsky, EK1
Ettinger, DS1
Grochow, LB1
Brundrett, RB1
Cates, AE1
Donehower, RC1
Egorin, MJ1
Sigman, LM1
Van Echo, DA1
Forrest, A1
Whitacre, MY1
Aisner, J1

Trials

1 trial available for hexamethylene bisacetamide and Nausea

ArticleYear
Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube.
    Cancer research, 1991, Apr-01, Volume: 51, Issue:7

    Topics: Acetamides; Adult; Aged; Biological Availability; Confusion; Drug Evaluation; Female; Gastrointestin

1991

Other Studies

2 other studies available for hexamethylene bisacetamide and Nausea

ArticleYear
Phase I and pharmacologic study of hexamethylene bisacetamide in patients with advanced cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:12

    Topics: Acetamides; Acidosis; Adult; Aged; Central Nervous System Diseases; Chromatography, Gas; Dose-Respon

1986
Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.
    Cancer research, 1987, Jan-15, Volume: 47, Issue:2

    Topics: Acetamides; Acidosis; Drug Administration Schedule; Drug Evaluation; Hematopoiesis; Humans; Kidney;

1987